PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Recombinant Products, National Institutes for Food and Drug Control, Beijing, China.\', \'Department of Cell Engineering, Beijing Institute of Biotechnology, Beijing, China.\', \'Department of Geriatrics and National Clinical Research Center for Geriatrics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.\', \'Department of Arboviral Vaccine, National Institutes for Food and Drug Control, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fcimb.2022.802147
?:doi
?:hasPublicationType
?:journal
  • Frontiers in cellular and infection microbiology
is ?:pmid of
?:pmid
?:pmid
  • 35310850
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.703
?:rankingScore_hIndex
  • 43
?:title
  • Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all